Submitted by Anonymous (not verified) on 3 February 2026 - 9:45
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 9, Status: Authorised